IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 251 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,116 | +348.2% | 115,889 | +396.0% | 0.00% | – |
| Q2 2023 | $249 | -100.0% | 23,365 | -91.5% | 0.00% | -100.0% |
| Q4 2021 | $3,214,000 | -66.6% | 275,640 | -62.5% | 0.00% | -66.7% |
| Q3 2021 | $9,609,000 | +125.2% | 735,721 | +96.4% | 0.01% | +100.0% |
| Q4 2020 | $4,266,000 | +1346.1% | 374,569 | +1212.0% | 0.01% | +500.0% |
| Q2 2020 | $295,000 | +94.1% | 28,549 | +89.1% | 0.00% | – |
| Q1 2020 | $152,000 | -97.6% | 15,100 | -96.9% | 0.00% | -100.0% |
| Q4 2019 | $6,410,000 | – | 481,624 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |